CANY
IDXX icon

Caxton Associates (New York)’s Idexx Laboratories IDXX Stock Holding History

Caxton Associates (New York)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-927
Closed -$501K – 535
2024
Q1 		$501K Buy
+927
New +$507K 0.03% 322
2023
Q4 		– Sell
-3,911
Closed -$1.71M – 500
2023
Q3 		$1.71M Sell
3,911
-362
-8% -$181K 0.24% 71
2023
Q2 		$2.15M Buy
4,273
+2,927
+217% +$1.4M 0.32% 62
2023
Q1 		$673K Buy
+1,346
New +$644K 0.1% 215
2022
Q4 		– Sell
-4,823
Closed -$1.57M – 524
2022
Q3 		$1.57M Buy
4,823
+2,948
+157% +$1.08M 0.21% 45
2022
Q2 		$658K Buy
+1,875
New +$765K 0.06% 206
2022
Q1 		– Sell
-478
Closed -$315K – 597
2021
Q4 		$315K Buy
+478
New +$300K 0.03% 403
2021
Q2 		– Sell
-1,066
Closed -$522K – 530
2021
Q1 		$522K Buy
+1,066
New +$534K 0.05% 154
2019
Q3 		– Sell
-33,794
Closed -$9.3M – 463
2019
Q2 		$9.3M Buy
33,794
+31,178
+1,192% +$7.68M 1.12% 16
2019
Q1 		$585K Buy
2,616
+724
+38% +$149K 0.09% 123
2018
Q4 		$352K Hold
1,892
– – 0.06% 165
2018
Q3 		$472K Buy
+1,892
New +$459K 0.03% 241
2017
Q4 		– Sell
-1,700
Closed -$264K – 427
2017
Q3 		$264K Sell
1,700
-900
-35% -$142K 0.01% 451
2017
Q2 		$420K Buy
+2,600
New +$422K 0.02% 390

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caxton Associates (New York)'s IDXX Position: Q2 2024 in Review

Caxton Associates (New York) sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 927 shares — an estimated $501K sold.

Caxton Associates (New York) first reported a position in IDXX in Q2 2017 and held it in 14 quarters. The position peaked at $9.3M in Q2 2019. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Caxton Associates (New York) reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 927 Idexx Laboratories shares in Q2 2024, an estimated $501K.
  • Caxton Associates (New York) first reported a position in Idexx Laboratories in Q2 2017 and held it in 14 quarters.
  • Caxton Associates (New York)'s Idexx Laboratories position peaked at $9.3M in Q2 2019.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.